- Home
- QNME vs SCNX Comparison
QNME vs SCNX Comparison
Compare QNME & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QNME | SCNX |
|---|---|---|
| Founded | 2018 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Integrated Freight & Logistics | Other Pharmaceuticals |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.1M | 16.2M |
| IPO Year | 2024 | 2019 |
Fundamental Metrics
Financial Performance| Metric | QNME | SCNX |
|---|---|---|
| Price | $0.32 | $3.04 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 639.2K | 25.2K |
| Earning Date | 11-23-2026 | 11-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 47.83 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $5,850,681.00 | $3,831,778.00 |
| Revenue This Year | N/A | $743.36 |
| Revenue Next Year | N/A | $325.03 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 111.79 | 30.72 |
| 52 Week Low | $0.26 | $2.64 |
| 52 Week High | $1.40 | $106.25 |
Technical Indicators
Market Signals| Indicator | QNME | SCNX |
|---|---|---|
| Relative Strength Index (RSI) | 39.77 | 46.70 |
| Support Level | $0.28 | $2.64 |
| Resistance Level | $0.43 | $3.68 |
| Average True Range (ATR) | 0.05 | 0.24 |
| MACD | -0.01 | 0.25 |
| Stochastic Oscillator | 6.34 | 22.22 |
Price Performance
Historical ComparisonAbout QNME Quanome Technologies Inc. Common Stock
Quanome Technologies Inc operates in the midstream segment of the pharmaceutical industrial ecosystem, operating between upstream pharmaceutical manufacturers and downstream medical end customers. It sources products from multiple manufacturers and suppliers, and distribute them to hospitals, pharmaceutical distributors and other healthcare providers. Its principal product categories include infusion products, foods for special medical purposes, and specialty pharmaceuticals. It operates in one reportable segment serves its customers by providing pharmaceutical products in China. The company generates a substantial percentage of its revenue from selling pharmaceutical products on a direct basis.
About SCNX Scienture Holdings Inc.
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on the commercialization and development of products for the treatment of cardiovascular (CVS) and Central Nervous System (CNS) diseases. Scienture LLC launched its first commercial product for hypertension and is in the process of commercializing its second product for the treatment of opioid overdose. Its development pipeline consists of a broad range of novel product candidates including new potential treatments for migraine, thrombosis, pain and other related disorders.